346 related articles for article (PubMed ID: 29451718)
21. [Expression and significance of Notch1, Jagged1 and VEGF in human non-small cell lung cancer].
Jiang X; Zhou JH; Deng ZH; Qu XH; Jiang HY; Liu Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Dec; 32(6):1031-6. PubMed ID: 18182722
[TBL] [Abstract][Full Text] [Related]
22. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
23. miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).
He X; Chen SY; Yang Z; Zhang J; Wang W; Liu MY; Niu Y; Wei XM; Li HM; Hu WN; Sun GG
J Exp Clin Cancer Res; 2018 Sep; 37(1):230. PubMed ID: 30227870
[TBL] [Abstract][Full Text] [Related]
24. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients.
Zhu D; Chen H; Yang X; Chen W; Wang L; Xu J; Yu L
Diagn Pathol; 2014 Nov; 9():198. PubMed ID: 25410592
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of Homeobox B5 (HOXB5) Inhibits Cell Proliferation, Migration, and Invasion in Non-Small Cell Lung Cancer Cells Through Inactivation of the Wnt/β-Catenin Pathway.
Zhang B; Li N; Zhang H
Oncol Res; 2018 Jan; 26(1):37-44. PubMed ID: 28337958
[TBL] [Abstract][Full Text] [Related]
26. Modification of α2,6-sialylation mediates the invasiveness and tumorigenicity of non-small cell lung cancer cells in vitro and in vivo via Notch1/Hes1/MMPs pathway.
Yuan Q; Chen X; Han Y; Lei T; Wu Q; Yu X; Wang L; Fan Z; Wang S
Int J Cancer; 2018 Nov; 143(9):2319-2330. PubMed ID: 29981167
[TBL] [Abstract][Full Text] [Related]
27. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q
Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD.
Zhang Y; Xu X; Zhang M; Wang X; Bai X; Li H; Kan L; Zhou Y; Niu H; He P
BMC Cancer; 2016 May; 16():315. PubMed ID: 27184257
[TBL] [Abstract][Full Text] [Related]
29. Overexpression and biological function of TMEM48 in non-small cell lung carcinoma.
Qiao W; Han Y; Jin W; Tian M; Chen P; Min J; Hu H; Xu B; Zhu W; Xiong L; Lin Q
Tumour Biol; 2016 Feb; 37(2):2575-86. PubMed ID: 26392108
[TBL] [Abstract][Full Text] [Related]
30. LncNORAD interference inhibits tumor growth and lung cancer cell proliferation, invasion and migration by down-regulating CXCR4 to suppress RhoA/ROCK signaling pathway.
Wu Y; Shen QW; Niu YX; Chen XY; Liu HW; Shen XY
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5446-5455. PubMed ID: 32495879
[TBL] [Abstract][Full Text] [Related]
31. CCDC85B promotes non-small cell lung cancer cell proliferation and invasion.
Feng Y; Gao Y; Yu J; Jiang G; Zhang X; Lin X; Han Q; Rong X; Xu H; Li Q; Qiu X; Wang E
Mol Carcinog; 2019 Jan; 58(1):126-134. PubMed ID: 30242906
[TBL] [Abstract][Full Text] [Related]
32. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
33. TIMM50 promotes tumor progression via ERK signaling and predicts poor prognosis of non-small cell lung cancer patients.
Zhang X; Han S; Zhou H; Cai L; Li J; Liu N; Liu Y; Wang L; Fan C; Li A; Miao Y
Mol Carcinog; 2019 May; 58(5):767-776. PubMed ID: 30604908
[TBL] [Abstract][Full Text] [Related]
34. Enhanced expression of circular RNA hsa_circ_000984 promotes cells proliferation and metastasis in non-small cell lung cancer by modulating Wnt/β-catenin pathway.
Li XY; Liu YR; Zhou JH; Li W; Guo HH; Ma HP
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3366-3374. PubMed ID: 31081091
[TBL] [Abstract][Full Text] [Related]
35. COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance.
Shen L; Yang M; Lin Q; Zhang Z; Zhu B; Miao C
Oncol Rep; 2016 Aug; 36(2):877-85. PubMed ID: 27373316
[TBL] [Abstract][Full Text] [Related]
36. p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.
Gu MM; Gao D; Yao PA; Yu L; Yang XD; Xing CG; Zhou J; Shang ZF; Li M
Cancer Sci; 2018 Dec; 109(12):3783-3793. PubMed ID: 30281878
[TBL] [Abstract][Full Text] [Related]
37. Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis.
Yuan X; Wu H; Xu H; Han N; Chu Q; Yu S; Chen Y; Wu K
Sci Rep; 2015 May; 5():10338. PubMed ID: 25996086
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-219 is downregulated in non-small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2.
Sun X; Xu M; Liu H; Ming K
Mol Med Rep; 2017 Sep; 16(3):3557-3564. PubMed ID: 28714014
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA NSCLCAT1 increases non-small cell lung cancer cell invasion and migration through the Hippo signaling pathway by interacting with CDH1.
Zhao W; Zhang LN; Wang XL; Zhang J; Yu HX
FASEB J; 2019 Jan; 33(1):1151-1166. PubMed ID: 30148675
[TBL] [Abstract][Full Text] [Related]
40. Circadian clock gene Per2 downregulation in non‑small cell lung cancer is associated with tumour progression and metastasis.
Xiang R; Cui Y; Wang Y; Xie T; Yang X; Wang Z; Li J; Li Q
Oncol Rep; 2018 Nov; 40(5):3040-3048. PubMed ID: 30226549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]